HIGHLIGHTS
- who: . and collaborators from the First Hospital of Lanzhou University, China have published the research: Astragaloside IV attenuates ferroptosis after subarachnoid hemorrhage via Nrf2/HO-1 signaling pathway, in the Journal: (JOURNAL)
- what: This study provides concrete evidence to shed light on the therapeutic effect of AS-IV to lessen the severity of SAH-induced EBI by attenuating ferroptosis and activating Nrf2/ HO-1 pathway. frontiersin.org 10.3389/fphar.2022.924826 Liu et_al, 2022). The study showed that AS-IV treatment significantly reduced iron content, Lipid ROS, and MDA levels after SAH, and ameliorated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.